Maść Ichtiolowa

Ichthammol, the active ingredient in Maść Ichtiolowa, is an antiseptic/anti‑inflammatory presented as an ointment for topical use. It treats inflammatory skin conditions and promotes drainage of suppurative lesions in adults and children.

GNH USA supplies Maść Ichtiolowa as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Ichthammol ointment acts on inflammatory and infectious skin disorders, helping to reduce swelling, redness and promote lesion drainage. - Dermatitis: reduces inflammation and eases itching. - Eczema: calms flare‑ups and limits moisture loss. - Psoriasis: softens plaques and diminishes scaling. - Acne: limits bacterial growth and decreases pustule formation. - Furunculosis: aids in drainage of furuncles and relieves pain. - Abscesses: supports spontaneous drainage and limits secondary infection.

Topical application of ichthammol ointment may cause local reactions, most of which are mild and reversible.

Common Side Effects: - Mild skin irritation or burning sensation. - Redness at the application site. - Itching or pruritus. - Dryness or flaking of the treated skin. - Local allergic contact dermatitis.

Serious or Rare Side Effects: - Severe allergic reaction (e.g., anaphylaxis). - Bullous or vesicular dermatitis. - Extensive skin necrosis. - Systemic toxicity from excessive absorption (very rare).

Before using ichthammol ointment, consider the following safety measures. - Pregnancy: consult a healthcare professional; data are limited. - Breastfeeding: use with caution and under medical advice. - Age: not recommended for infants under two months without supervision. - Application: avoid eyes, mucous membranes and broken skin unless directed. - Allergy: discontinue use if severe irritation or allergic reaction occurs. - Store at room temperature: keep in the original container, protect from light and moisture.

Ichthammol ointment may interact with other topical agents; monitor for combined irritation.

Major Interactions (Avoid): - Concurrent use with potent topical corticosteroids may increase risk of skin atrophy. - Application under occlusive dressings can enhance systemic absorption. - Combining with other keratolytic agents (e.g., salicylic acid) may cause excessive irritation.

Moderate Interactions (Monitor Closely): - Use with other topical antibiotics may increase local irritation. - Co‑application with antiseptic solutions containing high alcohol content may reduce efficacy. - Patients on systemic immunosuppressants should be observed for delayed wound healing.